GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA
Otvos B, Grabowski M, Alban T, Golubovsky J, Neumann C, Rabjlenovic A, Bayik D, Lauko A, Bucala R, Vogelbaum M, Lathia J. GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA. Neuro-Oncology 2019, 21: vi103-vi103. PMCID: PMC6847914, DOI: 10.1093/neuonc/noz175.428.Peer-Reviewed Original ResearchProgression-free survivalShorter progression-free survivalMacrophage migration inhibitory factorOverall survivalGBM patientsMIF expressionSingle nucleotide polymorphismsRisk factorsSNP statusGBM developmentKarnofsky performance statusWorse overall prognosisShorter overall survivalImmune suppressive microenvironmentMigration inhibitory factorGBM cancer stem cellsCancer stem cellsMGMT methylation statusGenomic risk factorsFree survivalOverall prognosisPerformance statusSuppressor cellsCare therapyPrognostic factors